The Stanford Cardiovascular Institute's mission is to ignite new research and clinical applications to improve cardiovascular health. We strive to promote the exchange of ideas and collaboration among students, fellows, faculty, and scientists.
The program supports research to improve the neurocognitive outcomes and behavioral symptoms of 22q11 Deletion Syndrome. The program provides seed funding of up to $150,000/year, for 2 years.
Addressing the impact of structural racism and social injustice as key drivers in health disparities that affect maternal and child health are critical to advancing research.
The Stanford MCHRI Uytengsu-Hamilton 22q11 Neuropsychiatry Research Awards Program aims to promote innovative, transdisciplinary research to improve the neurocognitive outcomes and behavioral symptoms of 22q11.2 Deletion Syndrome.
